Glaxo Breaks Trend, Holds Dividend Steady
October 22, 2014 at 08:44 AM EDT
GlaxoSmithKline kept its dividend unchanged for the third quarter, breaking a run of steadily rising payouts, as U.S. pricing pressure on its top-selling lung drug Advair eroded sales and profit.